Kenneth L. Custer, Executive Vice President and President of Card Met Health at Eli Lilly and Company, recently reported several stock transactions that reflect his ongoing commitment to the company. The filings, submitted to the SEC, reveal a significant increase in his ownership of Eli Lilly shares, which is noteworthy for both the company and the pharmaceutical industry.

Background

Eli Lilly and Company, incorporated in Indiana, is a prominent player in the pharmaceutical preparations industry, classified under SIC code 2834. The company is known for its innovative products and has a strong presence in the market. Custer's recent filings include multiple Form 4 submissions, with the latest dated November 3, 2026, indicating his active participation in the company's stock transactions.

What the Filing Says

The recent SEC filing, accession number 0002071542-26-000006, details two notable transactions by Custer on November 1, 2026. He acquired 3,220 shares of common stock at no cost, and also reported a transaction involving 1,425.447 shares at a price of $1,417.54 per share. Following these transactions, Custer now holds a total of 13,360.544 shares of Eli Lilly common stock.

Impact

This increase in stock ownership by a high-ranking executive like Custer may have various implications. It could signal confidence in the company's future performance, which may resonate positively with investors and stakeholders. Additionally, as Eli Lilly competes in the pharmaceutical preparations sector, Custer's actions may influence perceptions of the company's stability and growth potential.

What's Next

The filing does not say what happens next.